Skip to content

Author

Cody A. Loy

We have 2 of 20 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

From probe to prodrug: immunoproteasome activity as a trigger for disease-selective therapeutics

Developing novel strategies that can exploit a cell's endogenous machinery to selectively release toxic compounds in diseased cells, while leaving healthy cells unaffected, is a challenging task to accomplish. An established approach involves antigen recognition on tumor cells, enabling targeted delivery of prodrugs in...

Cody A. Loy, Yijun Gu, Samuel C. Kim et al. · 0 citations
Open access Jul 2026

Two Mechanisms One Molecule: Developing a ‘Truly’ Bifunctional Degrader Targeting Rpn13 and CRBN

Truly-4 is the first noncovalent small molecule shown to degrade full-length Rpn13, a target previously approached using covalent or domain-restricted strategies, and establishes a generalizable framework for engineering bifunctional degraders that program the proteasome to execute parallel degradation mechanisms and h...

Cody A. Loy, Shawn E Vinogradsky, Darci J. Trader · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.